2 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow BioGaia Pharma AB: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Safety Study of Lactobacillus Reuteri BGP-014 in Patients With Ulcerative Colitis BGP-014, Placebo - Ulcerative Colitis | Phase 1 / Phase 2 | Completed | BioGaia Pharma AB | 35 | 2022-02-09 | 2025-06-26 |
| Safety and Preliminary Efficacy of BGP345A in Constipation Due to Opioid-based Medications Lactobacillus gasseri BGP345A, Placebo - Opioid-Induced Constipation | Phase 2 | Completed | BioGaia Pharma AB | 14 | 2022-01-20 | 2025-06-26 |
Colitis, Ulcerative (1) · Opioid-Induced Constipation (1)
France (1) · Sweden (1)
Petra J Lierud (1)